143 related articles for article (PubMed ID: 20373066)
21. Successful treatment of propafenone-induced cardiac arrest by calcium gluconate.
Chen X; Yang Z
Am J Emerg Med; 2017 Aug; 35(8):1209.e1-1209.e2. PubMed ID: 28390833
[TBL] [Abstract][Full Text] [Related]
22. Effect of CYP2D6*10 genotype on propafenone pharmacodynamics in Chinese patients with ventricular arrhythmia.
Cai WM; Xu J; Chen B; Zhang FM; Huang YZ; Zhang YD
Acta Pharmacol Sin; 2002 Nov; 23(11):1040-4. PubMed ID: 12421483
[TBL] [Abstract][Full Text] [Related]
23. Severe propafenone poisoning responded to temporary internal pacemaker.
Eray O; Fowler J
Vet Hum Toxicol; 2000 Oct; 42(5):289. PubMed ID: 11003121
[TBL] [Abstract][Full Text] [Related]
24. Cardiac electrophysiological effects of propafenone and its 5-hydroxylated metabolite in the conscious dog.
Boucher M; Chassaing C; Hamel JD; Poirier JM
Eur J Pharmacol; 1996 Nov; 315(2):171-7. PubMed ID: 8960881
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of CYP2D6 oxidation of dextromethorphan and propafenone in a Chinese population with atrial fibrillation.
Chow MS; White CM; Lau CP; Fan C; Tang MO
J Clin Pharmacol; 2001 Jan; 41(1):92-6. PubMed ID: 11144999
[TBL] [Abstract][Full Text] [Related]
26. Internally standardized simultaneous assay of propafenone and 5-hydroxypropafenone enantiomers in human plasma by means of high performance liquid chromatography.
Kern R
Methods Find Exp Clin Pharmacol; 1994 Apr; 16(3):203-10. PubMed ID: 7913980
[TBL] [Abstract][Full Text] [Related]
27. Plasma propafenone concentration in the evaluation of anti-arrhythmic efficacy.
Steurer G; Weber H; Schmidinger H; Plass H; Frey B; Pürerfellner H; Probst P
Eur Heart J; 1991 Apr; 12(4):526-32. PubMed ID: 2065687
[TBL] [Abstract][Full Text] [Related]
28. Enantioselective determination of propafenone and its metabolites in human plasma by liquid chromatography-mass spectrometry.
Zhong D; Chen X
J Chromatogr B Biomed Sci Appl; 1999 Jan; 721(1):67-75. PubMed ID: 10027638
[TBL] [Abstract][Full Text] [Related]
29. [HPLC determination of diprafenone and its active metabolite 5-hydroxydiprafenone in human plasma].
Zhong D; Blume H
Pharmazie; 1994 Jan; 49(1):38-41. PubMed ID: 8140128
[TBL] [Abstract][Full Text] [Related]
30. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
Malfatto G; Zaza A; Forster M; Sodowick B; Danilo P; Rosen MR
J Pharmacol Exp Ther; 1988 Aug; 246(2):419-26. PubMed ID: 3404440
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous determination of propafenone and 5-hydroxypropafenone enantiomers in plasma by chromatography on an amylose derived chiral stationary phase.
Pires de Abreu LR; Lanchote VL; Bertucci C; Cesarino EJ; Bonato PS
J Pharm Biomed Anal; 1999 Jun; 20(1-2):209-16. PubMed ID: 10704025
[TBL] [Abstract][Full Text] [Related]
32. Propafenone overdose.
Kerns W; English B; Ford M
Ann Emerg Med; 1994 Jul; 24(1):98-103. PubMed ID: 8010557
[TBL] [Abstract][Full Text] [Related]
33. Lethal suicidal intoxication with propafenone, after a history of self-inflicted injuries.
Maxeiner H; Klug E
Forensic Sci Int; 1997 Sep; 89(1-2):27-32. PubMed ID: 9306661
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of suicide attempt by megadose of propafenone and captopril.
Avci A; Yilmaz A; Celik M; Demir K; Keles F
Cardiovasc Toxicol; 2013 Sep; 13(3):230-3. PubMed ID: 23397376
[TBL] [Abstract][Full Text] [Related]
35. Enantioselective determination of diprafenone in human plasma.
Zhong D; Chen R; Fieger-Büschges H; Blume H
Pharmazie; 1997 Feb; 52(2):106-9. PubMed ID: 9122271
[TBL] [Abstract][Full Text] [Related]
36. Quantitation of R- and S-propafenone and of the main metabolite in plasma.
Böhm R; Ellrich R; Koytchev R
Pharmazie; 1995 Aug; 50(8):542-5. PubMed ID: 7568317
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings.
Labbé L; O'Hara G; Lefebvre M; Lessard E; Gilbert M; Adedoyin A; Champagne J; Hamelin B; Turgeon J
Clin Pharmacol Ther; 2000 Jul; 68(1):44-57. PubMed ID: 10945315
[TBL] [Abstract][Full Text] [Related]
38. [Life-threatening ventricular arrhythmia during simultaneous administration of propafenone and sotatol].
Gilewski W; Bednarska D; Sinkiewicz W
Kardiol Pol; 2009 Aug; 67(8):916-20; discussion 921. PubMed ID: 19784892
[TBL] [Abstract][Full Text] [Related]
39. Intravenous and oral propafenone for treatment of tachycardia in infants and children: pharmacokinetics and clinical response.
Ito S; Gow R; Verjee Z; Giesbrecht E; Dodo H; Freedom R; Tonn GR; Axelson JE; Zalzstein E; Rosenberg HC; Koren G
J Clin Pharmacol; 1998 Jun; 38(6):496-501. PubMed ID: 9650538
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group.
Zoble RG; Kirsten EB; Brewington J
Clin Pharmacol Ther; 1989 May; 45(5):535-41. PubMed ID: 2721109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
